Transcription Factor Driven Gene Regulation in COVID-19 Patients

Overview

Journal Viruses

Publisher MDPI

Specialty Microbiology

Date 2023 May 27

PMID 37243274

Authors

Daniele Santoni

Nimisha Ghosh

Carlo Derelitto

Indrajit Saha

Affiliations

Soon will be listed here.

Abstract

SARS-CoV-2 and its many variants have caused a worldwide emergency. Host cells colonised by SARS-CoV-2 present a significantly different gene expression landscape. As expected, this is particularly true for genes that directly interact with virus proteins. Thus, understanding the role that transcription factors can play in driving differential regulation in patients affected by COVID-19 is a focal point to unveil virus infection. In this regard, we have identified 19 transcription factors which are predicted to target human proteins interacting with Spike glycoprotein of SARS-CoV-2. Transcriptomics RNA-Seq data derived from 13 human organs are used to analyse expression correlation between identified transcription factors and related target genes in both COVID-19 patients and healthy individuals. This resulted in the identification of transcription factors showing the most relevant impact in terms of most evident differential correlation between COVID-19 patients and healthy individuals. This analysis has also identified five organs such as the blood, heart, lung, nasopharynx and respiratory tract in which a major effect of differential regulation mediated by transcription factors is observed. These organs are also known to be affected by COVID-19, thereby providing consistency to our analysis. Furthermore, 31 key human genes differentially regulated by the transcription factors in the five organs are identified and the corresponding KEGG pathways and GO enrichment are also reported. Finally, the drugs targeting those 31 genes are also put forth. This in silico study explores the effects of transcription factors on human genes interacting with Spike glycoprotein of SARS-CoV-2 and intends to provide new insights to inhibit the virus infection.

Citing Articles

Remodeling of the chromatin landscape in peripheral blood cells in patients with severe Delta COVID-19.

Akimov V, Tychinin D, Antonova O, Shaymardanov A, Voronina M, Deinichenko K Front Immunol. 2024; 15:1415317.

PMID: 39712003 PMC: 11662282. DOI: 10.3389/fimmu.2024.1415317.

Long COVID: Molecular Mechanisms and Detection Techniques.

Constantinescu-Bercu A, Lobiuc A, Caliman-Sturdza O, Oita R, Iavorschi M, Paval N Int J Mol Sci. 2024; 25(1).

PMID: 38203577 PMC: 10778767. DOI: 10.3390/ijms25010408.

References

Chen X, Zhang G, Tang Y, Peng Z, Pan H . The coronavirus diseases 2019 (COVID-19) pneumonia with spontaneous pneumothorax: a case report. BMC Infect Dis. 2020; 20(1):662. PMC: 7479294. DOI: 10.1186/s12879-020-05384-x. View

Zhang B, Yu Q, Huo D, Li J, Liang C, Li H . Arf1 regulates the ER-mitochondria encounter structure (ERMES) in a reactive oxygen species-dependent manner. FEBS J. 2018; 285(11):2004-2018. DOI: 10.1111/febs.14445. View

Brokatzky D, Hacker G . Mitochondria: intracellular sentinels of infections. Med Microbiol Immunol. 2022; 211(4):161-172. PMC: 9255486. DOI: 10.1007/s00430-022-00742-9. View

Vkovski P, Gerber M, Kelly J, Pfaender S, Ebert N, Lagache S . Determination of host proteins composing the microenvironment of coronavirus replicase complexes by proximity-labeling. Elife. 2019; 8. PMC: 6372286. DOI: 10.7554/eLife.42037. View

Fornes O, Castro-Mondragon J, Khan A, van der Lee R, Zhang X, Richmond P . JASPAR 2020: update of the open-access database of transcription factor binding profiles. Nucleic Acids Res. 2019; 48(D1):D87-D92. PMC: 7145627. DOI: 10.1093/nar/gkz1001. View

Enjuanes L, Almazan F, Sola I, Zuniga S . Biochemical aspects of coronavirus replication and virus-host interaction. Annu Rev Microbiol. 2006; 60:211-30. DOI: 10.1146/annurev.micro.60.080805.142157. View

Xie Z, Bailey A, Kuleshov M, Clarke D, Evangelista J, Jenkins S . Gene Set Knowledge Discovery with Enrichr. Curr Protoc. 2021; 1(3):e90. PMC: 8152575. DOI: 10.1002/cpz1.90. View

di Bari I, Franzin R, Picerno A, Stasi A, Cimmarusti M, Di Chiano M . Severe acute respiratory syndrome coronavirus 2 may exploit human transcription factors involved in retinoic acid and interferon-mediated response: a hypothesis supported by an analysis. New Microbes New Infect. 2021; 41:100853. PMC: 7912353. DOI: 10.1016/j.nmni.2021.100853. View

Wen W, Su W, Tang H, Le W, Zhang X, Zheng Y . Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing. Cell Discov. 2020; 6:31. PMC: 7197635. DOI: 10.1038/s41421-020-0168-9. View

10.

van Hemert M, van den Worm S, Knoops K, Mommaas A, Gorbalenya A, Snijder E . SARS-coronavirus replication/transcription complexes are membrane-protected and need a host factor for activity in vitro. PLoS Pathog. 2008; 4(5):e1000054. PMC: 2322833. DOI: 10.1371/journal.ppat.1000054. View

11.

Chapola H, De Bastiani M, Duarte M, Freitas M, Schuster J, de Vargas D . A comparative study of COVID-19 transcriptional signatures between clinical samples and preclinical cell models in the search for disease master regulators and drug repositioning candidates. Virus Res. 2023; 326:199053. PMC: 9877318. DOI: 10.1016/j.virusres.2023.199053. View

12.

Sardar R, Satish D, Gupta D . Identification of Novel SARS-CoV-2 Drug Targets by Host MicroRNAs and Transcription Factors Co-regulatory Interaction Network Analysis. Front Genet. 2020; 11:571274. PMC: 7591747. DOI: 10.3389/fgene.2020.571274. View

13.

Lin M, Dong H, Xie H, Li Y, Jia L . Why do we lack a specific magic anti-COVID-19 drug? Analyses and solutions. Drug Discov Today. 2021; 26(3):631-636. PMC: 7771376. DOI: 10.1016/j.drudis.2020.12.010. View

14.

Ahmed M, Zia Q, Haque A, Alqahtani A, Almarfadi O, Banawas S . Aminoglycosides as potential inhibitors of SARS-CoV-2 main protease: an in silico drug repurposing study on FDA-approved antiviral and anti-infection agents. J Infect Public Health. 2021; 14(5):611-619. PMC: 7871101. DOI: 10.1016/j.jiph.2021.01.016. View

15.

Li J, Li Q, Xie C, Zhou H, Wang Y, Zhang N . Beta-actin is required for mitochondria clustering and ROS generation in TNF-induced, caspase-independent cell death. J Cell Sci. 2004; 117(Pt 20):4673-80. DOI: 10.1242/jcs.01339. View

16.

Chen E, Tan C, Kou Y, Duan Q, Wang Z, Meirelles G . Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinformatics. 2013; 14:128. PMC: 3637064. DOI: 10.1186/1471-2105-14-128. View

17.

Gao L, Li G, Li J, He J, Zhang Y, Zhou H . Identification of the susceptibility genes for COVID-19 in lung adenocarcinoma with global data and biological computation methods. Comput Struct Biotechnol J. 2021; 19:6229-6239. PMC: 8605816. DOI: 10.1016/j.csbj.2021.11.026. View

18.

Xu S, Liu Y, Ding Y, Luo S, Zheng X, Wu X . The zinc finger transcription factor, KLF2, protects against COVID-19 associated endothelial dysfunction. Signal Transduct Target Ther. 2021; 6(1):266. PMC: 8273371. DOI: 10.1038/s41392-021-00690-5. View

19.

Chen L, Marishta A, Ellison C, Verzi M . Identification of Transcription Factors Regulating SARS-CoV-2 Entry Genes in the Intestine. Cell Mol Gastroenterol Hepatol. 2020; 11(1):181-184. PMC: 7428702. DOI: 10.1016/j.jcmgh.2020.08.005. View

20.

Mosharaf M, Reza M, Kibria M, Ahmed F, Kabir M, Hasan S . Computational identification of host genomic biomarkers highlighting their functions, pathways and regulators that influence SARS-CoV-2 infections and drug repurposing. Sci Rep. 2022; 12(1):4279. PMC: 8915158. DOI: 10.1038/s41598-022-08073-8. View